William K. Holstein
Nessuna posizione attualmente
Profilo
William K.
Holstein worked as a Senior Vice President of Business Development at Gemmus Pharma, Inc..
Mr. Holstein attended The University of Colorado where he earned an undergraduate degree.
Precedenti posizioni note di William K. Holstein
| Società | Posizione | Fine |
|---|---|---|
Gemmus Pharma, Inc.
 Gemmus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Gemmus Pharma Inc. develops pharmaceutical products for the treatment of infectious diseases. The firm focus on the development of pharmaceutical products for the treatment of influenza and other viral infectious diseases. It develops GP1001, a non-peptidic eiconsanoid analog that is used for the treatment of serious influenza infections that require hospitalization as either a stand-alone treatment or co-therapy with an antiviral drug, as oseltamivir. The company was founded by Daryl H. Faulds in 2007 and is headquartered in San Francisco, CA. | Direttore Finanziario/CFO | - |
Formazione di William K. Holstein
| The University of Colorado | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Gemmus Pharma, Inc.
Gemmus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Gemmus Pharma Inc. develops pharmaceutical products for the treatment of infectious diseases. The firm focus on the development of pharmaceutical products for the treatment of influenza and other viral infectious diseases. It develops GP1001, a non-peptidic eiconsanoid analog that is used for the treatment of serious influenza infections that require hospitalization as either a stand-alone treatment or co-therapy with an antiviral drug, as oseltamivir. The company was founded by Daryl H. Faulds in 2007 and is headquartered in San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- William K. Holstein
